Product information. Pneumovax-23 (pneumococcal vaccine polyvalent).West Point, PA: Merck Sharp & Dohme, April 1986
2.
Product information. PnuImmune (pneumococcal vaccine polyvalent).Pearl River, NY: Lederle Laboratories, November 1985.
3.
LinnemannCCJr., FirstMR, SchiffmanG,. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine.Arch Intern Med1986; 146: 1554–6.
4.
Centers for Disease Control.Update: pneumococcal polysaccharide vaccine usage — United States.MMWR1984; 33: 273–81.
5.
BolanG, BroomeCV, FacklamRR, PlikaytisBD, FraserDW, SchlechWFIII, Pneumococcal vaccine efficacy in selected populations in the United States.Ann Intern Med1986; 104: 1–6.
6.
LawrenceEM, EdwardsKM, SchiffmanG, ThompsonJM, VaughnWK, WrightPF. Pneumococcal vaccine in normal children: primary and secondary vaccination.Am J Dis Child1983; 137: 846–50.
7.
WeintrubPS, SchiffmanG, AddiegoJEJr.Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle-cell anemia.J Pediatr1984; 105: 261–3.
8.
GiebinkGS, LeCT, SchiffmanG.Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides.J Pediatr1984; 105: 576–82.
9.
HillemanMR, CarlsonAJJr., McleanAA, VellaPP, WeibelRE, WoodhourAF,. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.Rev Infect Dis1981; 3: S31–42.
